Eli Lilly starts first study of potential COVID-19 antibody treatment

Video Credit: Reuters Studio
Published on June 1, 2020 - Duration: 01:07s

Eli Lilly starts first study of potential COVID-19 antibody treatment

Eli Lilly said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.

This report produced by Yahaira Jacquez.


Eli Lilly starts first study of potential COVID-19 antibody treatment

Drugmaker Eli Lilly on Monday said it started early human trials of the worldโ€™s first potential antibody treatment for Covid-19.

Lilly said the first phase of the trial will track whether the treatment is safe and well-tolerated in patients hospitalized with the novel coronavirus.

The treatment uses an antibody designed to block the spike-shaped protein structures of the coronavirus from locking on to human cells, thus neutralizing it.

Lilly said the antibody treatment was developed after it was identified from a blood sample taken from one of the first U.S. patients who recovered from Covid-19.

The treatment was created in collaboration with AbCellera Biologics, a Canadian biotech company Lilly partnered with in March.

If the drug is show to be safe, Lilly said it will move on to the next phase of testing, which involves studying the potential treatment in non-hospitalized COVID-19 patients.

It says it expects results from that stage of the study by the end of June.

You are here

Related videos from verified sources

PM hails British scientists who led coronavirus treatment 02:36
Video credit: ODN - Published on June 16, 2020 

Eli Lilly COVID-19 Treatment In Testing 00:33
Video credit: Wochit - Published on June 11, 2020 

WHO set to resume hydroxychloroquine trial to battle covid-19 02:33
Video credit: HT Digital Content - Published on June 4, 2020 

You might like